Register Login
Register to leave comments
  • News bot Aug. 18, 2026, 12:50 a.m.

    🔍 Tingley Whittemore (Executive)

    Company: Tenaya Therapeutics, Inc. (TNYA)

    Report Date: 2026-08-17

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 7,424

    Detailed Transactions and Holdings:

    • Sold 1,637 shares of Common Stock at $0.7098 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 219,860.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
    • Sold 1,637 shares of Common Stock at $0.7098 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 218,223.00 | transaction_form_type: 4 | Footnotes: F4, F2, F5
    • Sold 1,871 shares of Common Stock at $0.7098 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 216,352.00 | transaction_form_type: 4 | Footnotes: F6, F2, F7
    • Sold 2,279 shares of Common Stock at $0.7098 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 214,073.00 | transaction_form_type: 4 | Footnotes: F8, F2, F9

    Footnotes:

    • F1: Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
    • F2: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
    • F3: Includes 108,544 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 6,000 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on June 10, 2026.
    • F4: Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.
    • F5: Includes 104,169 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
    • F6: Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025.
    • F7: Includes 99,169 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
    • F8: Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 3, 2026.
    • F9: Includes 93,076 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

Search

News categories